Garry Nolan - Dec 1, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Director
Signature: /s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Stock symbol: AKYA
Transactions as of: Dec 1, 2022
Transactions value $: -$66,788
Form type: 4
Date filed: 12/2/2022, 03:00 PM
Previous filing: Nov 17, 2022
Next filing: Dec 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKYA	Common Stock	Sale	-$66.8K	-5K	-0.84%	$13.36	593K	Dec 1, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $13.25 and $13.50, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $13.25 and $13.50, inclusive. The reporting person undertakes to provide to Akoya Biosciences, Inc., any security holder of Akoya Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.